No definition available.
Infections specific to the perinatal period
P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
438 |
4. Check minimum number of eventsNone |
438 |
5. Include endpoints |
438 |
6. Filter based on genotype QC (FinnGen only) |
417 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P
- Name in latin
- Infectiones temporis perinatalis specificae
Infections specific to the perinatal period
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 42413 | 17614 | 24798 |
| Only index persons | 19844 | 8095 | 11749 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.61 | 0.50 | 0.69 |
| Only index persons | 0.39 | 0.30 | 0.45 |
| Median age at first event (years) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 417 | 236 | 181 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.08 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 437
- Matched controls
- 4368
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
+∞
177.5
158
*
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
+∞
165.4
148
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
5.0
30.0
72
166
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
7.5
28.5
43
63
P39.1
ICD-10 Finland
Neonatal conjunctivitis and dacryocystitis
+∞
26.3
25
*
P36.0
ICD-10 Finland
Sepsis of newborn due to streptococcus, group B
+∞
24.2
23
*
P36.99
ICD-10 Finland
Bacterial sepsis of newborn, unspecified
+∞
22.1
21
*
P07.3
ICD-10 Finland
Other preterm infants
4.2
21.4
62
165
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
18.4
20.3
31
18
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
11.5
13.2
24
22
P36.3
ICD-10 Finland
Sepsis of newborn due to other and unspecified staphylococci
+∞
12.6
12
*
P39.4
ICD-10 Finland
Neonatal skin infection
+∞
11.5
11
*
P39.0
ICD-10 Finland
Neonatal infective mastitis
+∞
10.5
10
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.0
8.2
36
125
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
6.3
7.9
20
33
WX722
NOMESCO Finland
PEEP
3.9
7.9
23
61
P02.7
ICD-10 Finland
Fetus and newborn affected by chorioamnionitis
45.8
7.7
9
*
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
3.8
7.6
23
63
ZX198
NOMESCO Finland
Other local administration
11.1
7.3
13
12
602
Kela drug reimbursment
Children's severe malnutrition
2.8
6.6
33
124
P38
ICD-10 Finland
Omphalitis of newborn with or without mild haemorrhage
70.8
6.4
7
*
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
3.1
6.3
26
87
P35.1
ICD-10 Finland
Congenital cytomegalovirus infection
+∞
6.3
6
*
P36.4
ICD-10 Finland
Sepsis of newborn due to Escherichia coli
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
18
65
2.84
3.90
3.4
4.4
32.28
22.27
umol/l
1.06
18
65
26
129
2.08
2.92
10.3
11.9
0.67
0.63
%
0.23
26
129
8
20
4.05
2.58
1.1
1.2
—
—
—
0
0
48
310
1.62
2.37
2.4
2.1
—
—
—
0
0
48
311
1.61
2.34
2.2
2.0
—
—
—
0
0
8
24
3.37
2.19
1.3
1.1
—
—
—
0
0
362
3377
1.42
2.02
12.3
10.3
22.72
22.71
mg/l
0.00
246
2249
57
400
1.49
1.97
2.4
2.0
—
—
—
0
0
83
628
1.40
1.93
3.4
3.7
4.11
3.59
e6/l
0.11
42
354
136
1122
1.31
1.79
4.4
4.5
—
—
—
0
0
6
18
3.36
1.75
1.2
1.4
—
—
—
0
0
6
18
3.36
1.75
1.2
1.4
—
—
—
0
0
6
18
3.36
1.75
1.2
1.4
—
—
—
0
0
17
89
1.95
1.72
1.5
2.2
—
—
—
0
0
21
119
1.80
1.69
2.3
2.2
—
—
—
0
0
6
19
3.19
1.66
1.0
1.0
—
—
—
0
0
6
19
3.19
1.66
1.3
1.1
65.33
336.16
u/l
—
6
19
8
31
2.61
1.66
1.1
1.1
—
—
—
0
0
55
399
1.43
1.63
1.7
1.4
17.12
18.68
nmol/l
0.51
46
350
111
903
1.31
1.61
3.1
3.1
—
—
—
0
0
156
1328
1.27
1.59
3.5
3.3
0.00
0.00
estimate
-0.00
29
233
170
1464
1.26
1.57
13.5
11.8
1.23
1.23
mmol/l
0.08
162
1397
42
292
1.48
1.55
2.1
2.4
6.61
5.48
u/l
0.66
30
189
155
1324
1.26
1.53
5.3
4.8
0.00
0.00
estimate
-0.00
29
240
80
626
1.34
1.52
3.5
3.6
0.66
0.85
e6/l
0.26
38
353
81
638
1.33
1.47
3.1
3.5
0.00
0.00
estimate
-0.00
30
231
19
110
1.76
1.45
1.3
4.1
64.08
63.74
g/l
0.06
19
102
176
1534
1.25
1.44
12.7
11.1
1.23
1.22
mmol/l
0.42
162
1405
6
22
2.75
1.44
1.3
1.0
—
—
—
0
0
155
1334
1.25
1.42
3.6
3.4
0.00
0.00
estimate
-0.00
30
235
15
81
1.88
1.41
15.9
15.9
72.40
70.50
%
0.18
15
81
120
1003
1.27
1.40
4.2
4.2
0.25
0.19
e6/l
0.19
84
762
125
1052
1.26
1.38
7.1
7.7
19.26
19.97
umol/l
0.07
112
956
6
23
2.63
1.37
1.3
1.1
—
—
—
0
0
5
17
2.96
1.36
1.0
1.2
—
—
—
0
0
318
2974
1.25
1.30
15.4
11.6
3.91
3.91
mmol/l
0.06
311
2863
20
123
1.66
1.26
2.4
2.3
—
—
—
0
0
6
25
2.42
1.24
1.2
1.2
0.42
0.42
nmol/l
—
6
25
25
164
1.56
1.23
3.6
4.3
—
—
—
0
0
106
891
1.25
1.18
3.0
3.3
2.61
2.70
mg/l
0.20
95
796
17
102
1.69
1.18
2.5
2.2
—
—
—
0
0
17
102
1.69
1.18
2.5
2.2
—
—
—
0
0
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
16
95
1.71
1.15
1.3
2.1
—
—
—
0
0
92
764
1.26
1.13
3.7
2.7
2.39
2.40
mmol/l
0.33
81
704
16
96
1.69
1.11
2.6
2.2
—
—
—
0
0
16
96
1.69
1.11
2.6
2.3
—
—
—
0
0
22
144
1.56
1.10
3.5
2.3
—
—
—
0
0
12
66
1.84
1.10
1.8
1.6
4.03
4.96
iu/l
—
6
23
199
1795
1.20
1.09
6.9
5.4
124.97
120.05
u/l
0.34
183
1681
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
7
32
2.21
1.08
1.0
1.0
—
—
—
0
0
7
32
2.21
1.08
1.0
1.3
—
—
—
0
0
7
33
2.14
1.06
1.1
1.5
—
—
—
0
0
316
2980
1.22
1.05
15.4
11.6
139.43
139.47
mmol/l
0.15
309
2888
22
146
1.53
1.05
1.8
1.8
—
—
—
0
0
79
651
1.26
1.04
2.8
2.9
1.02
1.02
kg/l
1.58
18
106
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
9
157
0.56
1.00
1.1
1.1
—
—
—
0
0
7
35
2.01
1.00
1.1
1.0
—
—
—
0
0
40
303
1.35
0.98
1.3
1.3
306.77
136.52
iu/ml
—
8
93
14
85
1.67
0.95
2.3
1.8
—
—
—
0
0
34
253
1.37
0.93
2.2
2.0
207.75
168.88
u/ml
0.31
16
110
342
3268
1.21
0.90
17.8
14.3
13.69
13.26
%
1.51
335
3200
84
710
1.23
0.90
11.1
9.0
1.03
0.96
mmol/l
0.09
60
495
34
255
1.36
0.89
1.6
1.4
536.67
29515850.73
pmol/l
0.50
27
227
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
6
29
2.08
0.89
2.0
2.2
—
—
—
0
0
60
490
1.26
0.87
4.1
4.9
5.23
1.34
mg/l
0.52
39
340
8
44
1.83
0.86
1.0
1.0
—
—
—
0
0
34
257
1.35
0.86
2.2
2.0
—
—
—
0
0
324
3086
1.19
0.86
8.9
8.3
26.01
24.19
u/l
0.76
310
2975
96
1103
0.83
0.84
4.2
3.1
—
—
—
0
0
139
1544
0.85
0.81
1.7
1.8
0.82
3.20
u/ml
2.79
23
288
8
47
1.71
0.81
6.0
8.8
2.67
2.38
mg/l
—
8
37
19
268
0.70
0.79
1.2
1.3
—
—
—
0
0
14
90
1.57
0.79
1.2
3.8
—
—
—
0
0
87
749
1.20
0.78
9.7
9.4
0.13
1.19
mmol/l
1.21
70
585
16
107
1.51
0.77
4.7
4.9
3.54
3.28
mmol/l
0.59
16
102
6
34
1.77
0.76
9.3
7.9
—
—
—
0
0
6
34
1.77
0.76
1.2
1.0
—
—
—
0
0
6
34
1.77
0.76
2.0
1.2
—
—
—
0
0
5
24
2.09
0.74
1.2
2.0
—
—
—
0
0
398
3881
1.28
0.74
18.2
14.8
4.61
4.64
e12/l
0.50
374
3679
193
1781
1.15
0.73
3.1
2.7
2.62
2.60
mmol/l
0.10
185
1668
5
25
2.01
0.73
1.6
1.9
1.43
1.56
mg/l
—
5
18
5
25
2.01
0.73
1.6
1.9
1.40
7.58
mg/l
—
5
18
5
25
2.01
0.73
1.6
1.9
2.53
5.29
mg/l
—
5
17
5
25
2.01
0.73
1.6
1.9
0.48
1.06
mg/l
—
5
19
7
39
1.81
0.72
2.0
1.3
—
—
—
0
0
17
117
1.47
0.72
2.3
3.0
67.40
84.16
ml/min/173m2
—
5
32
7
40
1.76
0.71
2.0
1.5
—
—
—
0
0
5
26
1.93
0.71
1.6
2.0
1.41
1.05
mg/l
—
5
19
398
3885
1.27
0.70
18.5
15.1
132.57
133.54
g/l
0.70
392
3813
21
284
0.73
0.70
1.0
1.2
—
—
—
0
0
7
41
1.72
0.70
1.0
1.2
—
—
—
0
0
7
41
1.72
0.70
9.7
10.7
—
—
—
0
0
9
58
1.56
0.70
1.2
1.3
—
—
—
0
0
397
3875
1.26
0.69
18.3
14.9
274.86
270.44
e9/l
0.59
372
3689
167
1810
0.87
0.68
2.2
2.1
—
—
—
0
0
397
3877
1.26
0.67
18.9
15.4
39.52
39.75
%
0.46
381
3689
80
694
1.19
0.67
9.4
9.1
22.84
23.62
mmol/l
1.56
80
694
7
43
1.64
0.67
4.3
5.8
—
—
—
0
0
78
676
1.19
0.66
1.8
1.5
97.98
99.13
pmol/l
0.06
48
358
11
70
1.59
0.65
1.7
1.5
—
—
—
0
0
232
2183
1.13
0.63
10.0
10.5
3.27
3.44
e9/l
0.64
192
1826
24
182
1.34
0.62
1.7
1.6
1091.06
1126.66
nmol/l
0.06
18
137
8
49
1.64
0.62
1.9
1.7
—
—
—
0
0
36
290
1.26
0.61
11.8
9.7
105.06
105.39
mmol/l
0.19
36
290
60
512
1.20
0.61
1.9
1.7
1.60
1.18
mmol/l
0.51
55
474
0
21
0.00
0.60
0.0
2.1
—
—
—
0
0
182
1692
1.13
0.59
3.0
2.6
1.16
1.07
mmol/l
0.87
174
1596
215
2024
1.12
0.56
8.0
8.8
49.28
49.68
%
0.17
210
1936
17
124
1.39
0.56
1.2
1.4
—
—
—
0
0
17
124
1.39
0.56
1.2
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
37
1.63
0.55
2.0
1.2
—
—
—
0
0
6
38
1.59
0.54
8.3
6.8
—
—
—
0
0
6
38
1.59
0.54
8.3
7.1
—
—
—
0
0
16
213
0.74
0.51
1.2
1.8
—
—
—
0
0
43
363
1.20
0.50
4.9
3.2
1166.32
1394.04
ng/l
0.11
19
204
33
271
1.23
0.50
2.0
2.4
4.49
7.73
iu/l
2.85
24
182
33
271
1.23
0.50
5.1
4.2
5.74
9.38
mg/mmol
0.44
27
219
169
1580
1.11
0.49
4.2
3.2
36.85
36.35
mmol/mol
0.20
160
1481
192
1812
1.11
0.46
3.2
2.8
4.29
4.30
mmol/l
0.03
185
1724
218
2071
1.10
0.46
8.3
8.9
35.56
34.90
%
0.34
213
1981
80
718
1.14
0.46
5.8
5.5
1.14
1.11
inr
0.14
26
206
10
69
1.46
0.44
2.6
1.5
—
—
—
0
0
5
31
1.62
0.43
4.0
1.7
—
—
—
0
0
23
283
0.80
0.43
1.4
1.3
—
—
—
0
0
6
95
0.63
0.42
1.0
1.0
18.50
19.17
mmol/l
—
6
95
0
16
0.00
0.41
0.0
1.1
—
1164.31
—
0
16
11
79
1.40
0.41
3.2
4.3
90.00
5.09
u/ml
0.48
11
79
223
2130
1.09
0.41
4.3
4.4
8.97
6.91
mm/h
1.27
209
1981
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
31
260
1.21
0.40
2.9
1.8
2.43
2.41
mmol/l
0.27
25
214
0
18
0.00
0.40
0.0
1.2
—
208.91
—
0
18
86
784
1.12
0.39
14.7
12.9
24.64
24.73
mmol/l
0.12
86
784
0
19
0.00
0.39
0.0
4.6
—
—
—
0
0
186
1765
1.09
0.39
3.1
2.7
1.36
1.41
mmol/l
0.86
178
1664
5
36
1.39
0.38
1.0
1.6
168.80
118.06
%
—
5
36
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
12
89
1.36
0.38
1.4
2.2
—
—
—
0
0
13
98
1.34
0.37
2.3
4.4
26.00
26.14
%
0.02
13
98
16
125
1.29
0.37
11.5
13.9
92.99
95.69
%
0.37
16
125
13
99
1.32
0.35
1.2
1.2
199.83
314.36
iu/ml
—
6
28
6
42
1.43
0.35
1.8
1.4
—
—
—
0
0
16
126
1.28
0.35
13.7
9.0
22.38
23.18
mmol/l
0.61
16
121
6
43
1.40
0.35
3.5
1.6
—
—
—
0
0
159
1509
1.08
0.32
3.6
4.3
27.77
26.33
u/l
0.22
146
1449
41
361
1.15
0.32
2.7
2.3
16801.80
7894.14
u/l
—
6
108
11
141
0.77
0.30
1.1
1.3
—
—
—
0
0
35
396
0.87
0.29
1.1
1.2
—
3.30
—
0
5
25
290
0.85
0.28
1.6
1.4
—
—
—
0
0
12
94
1.28
0.28
1.2
1.4
—
—
—
0
0
176
1686
1.07
0.28
3.9
3.3
57.74
46.98
ug/l
0.38
167
1596
49
443
1.12
0.27
2.2
2.7
374.05
350.88
nmol/l
0.34
44
424
13
104
1.26
0.26
2.3
4.4
10.23
8.09
%
0.71
13
104
21
178
1.19
0.26
1.4
1.3
—
—
—
0
0
5
73
0.68
0.26
1.0
1.2
—
14.86
—
0
8
199
1921
1.07
0.25
2.5
2.2
5.57
5.33
mmol/l
0.84
177
1743
11
87
1.27
0.24
2.8
5.9
92.91
93.78
%
0.04
11
87
6
82
0.73
0.24
1.2
1.6
2.84
6.23
ug/l
—
6
77
172
1659
1.06
0.22
9.5
6.5
6.29
6.04
mmol/l
0.56
164
1549
10
124
0.80
0.22
1.0
1.2
—
—
—
0
0
5
42
1.19
0.21
4.2
3.0
62.20
56.50
umol/l
—
5
42
5
42
1.19
0.21
3.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
17.0
—
—
—
0
0
0
10
0.00
0.21
0.0
17.1
—
26.40
—
0
10
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
8
101
0.79
0.21
1.3
1.1
—
—
—
0
0
5
43
1.16
0.21
3.6
2.8
35.00
52.83
u/ml
—
5
35
6
48
1.25
0.20
1.0
5.2
—
—
—
0
0
6
48
1.25
0.20
1.0
5.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
0.97
—
0
6
9
111
0.81
0.20
2.1
1.6
—
—
—
0
0
6
49
1.23
0.20
1.2
1.4
—
—
—
0
0
15
127
1.19
0.19
11.9
13.7
0.69
0.74
%
0.27
15
127
11
90
1.23
0.19
1.3
1.7
—
—
—
0
0
41
376
1.10
0.19
7.0
7.2
4.78
6.54
umol/l
0.95
35
313
33
299
1.11
0.19
8.5
6.8
2426.16
715.45
ng/l
0.90
27
252
29
261
1.12
0.18
3.5
2.4
27.58
30.80
u/l
0.43
24
212
55
585
0.93
0.16
2.3
2.1
—
—
—
0
0
64
676
0.94
0.16
2.4
2.3
—
—
—
0
0
8
73
1.10
0.15
1.4
1.3
—
—
—
0
0
8
73
1.10
0.15
1.4
1.3
—
—
—
0
0
8
73
1.10
0.15
1.4
1.3
—
—
—
0
0
13
150
0.86
0.15
7.8
5.8
125.85
176.99
ng/l
0.41
13
141
9
82
1.10
0.15
4.1
4.4
43.78
50.89
%
—
9
82
20
223
0.89
0.15
1.9
2.0
—
—
—
0
0
44
411
1.08
0.14
1.3
1.4
1.35
1.37
%
0.09
38
373
22
198
1.12
0.14
1.2
1.1
10.90
6.31
u/ml
0.46
16
126
257
2525
1.04
0.14
3.9
3.2
14.32
14.36
pmol/l
0.10
232
2253
8
96
0.83
0.14
1.6
1.4
—
—
—
0
0
8
96
0.83
0.14
1.3
1.1
—
—
—
0
0
47
442
1.07
0.13
3.5
2.4
24.29
25.99
ng/l
0.05
14
155
17
151
1.13
0.13
1.3
1.4
0.22
0.20
g/l
0.43
17
145
12
104
1.16
0.12
2.3
4.4
—
—
—
0
0
17
152
1.12
0.12
1.2
1.4
1.18
1.15
g/l
0.26
17
145
12
105
1.15
0.11
1.3
1.4
—
—
—
0
0
26
241
1.08
0.10
1.7
2.2
11.59
8.26
nmol/l
0.49
21
209
280
2832
0.97
0.10
4.3
3.6
2.01
1.99
mu/l
0.11
260
2655
5
45
1.11
0.10
1.0
1.8
7.57
7.71
u/ml
—
5
34
30
281
1.07
0.09
2.1
1.9
—
—
—
0
0
69
665
1.04
0.09
3.8
3.2
—
—
—
0
0
106
1033
1.03
0.09
2.8
2.6
—
—
—
0
0
5
60
0.83
0.08
2.2
2.5
—
—
—
0
0
5
65
0.77
0.08
1.0
1.4
—
184.00
—
0
15
13
117
1.11
0.08
1.8
1.3
—
—
—
0
0
7
83
0.84
0.07
1.6
1.4
—
—
—
0
0
22
206
1.07
0.07
1.8
1.7
—
—
—
0
0
8
91
0.88
0.07
2.4
2.1
0.18
0.13
nmol/l
—
8
73
47
487
0.96
0.06
1.1
1.1
—
—
—
0
0
16
172
0.93
0.06
1.2
1.1
1.06
0.65
u/ml
—
8
77
30
314
0.95
0.06
1.3
1.2
2.30
2.61
u/ml
0.11
24
230
11
100
1.10
0.05
2.2
1.7
—
—
—
0
0
34
328
1.04
0.04
1.2
1.2
8.17
7.15
u/ml
0.11
25
245
21
200
1.05
0.03
1.3
1.4
—
—
—
0
0
19
181
1.05
0.03
1.2
1.1
26.50
10.07
u/ml
0.37
12
108
182
1833
0.99
0.03
10.8
6.3
109.58
111.55
ml/min/173m2
0.42
120
1164
54
531
1.02
0.02
8.5
6.1
32.61
30.97
s
0.88
54
524
33
322
1.03
0.01
1.2
1.2
0.45
1.06
u/ml
1.28
24
230
34
346
0.98
0.00
1.2
1.2
2.11
10.23
u/ml
—
10
103
38
374
1.02
0.00
1.2
1.2
8.83
14.84
iu/ml
—
6
83
99
984
1.01
0.00
2.7
2.4
—
—
—
0
0
15
152
0.99
0.00
1.9
1.9
—
—
—
0
0
15
146
1.03
0.00
1.5
1.3
—
—
—
0
0
36
355
1.01
0.00
1.6
1.2
—
—
—
0
0
13
133
0.98
0.00
1.5
1.3
—
—
—
0
0
35
348
1.01
0.00
1.3
1.3
3.30
3.61
u/ml
0.06
25
244
364
3639
1.00
0.00
4.0
3.9
—
—
—
0
0
8
80
1.00
0.00
1.3
1.8
211.50
139.65
ng/l
—
8
75
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
9
90
1.00
-0.00
1.3
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
7.8
—
3.52
—
0
9
8
79
1.01
-0.00
2.0
3.6
724.38
782.81
e6/l
—
8
79
0
5
0.00
-0.00
0.0
1.0
—
85.60
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
305.00
—
0
5
6
62
0.97
-0.00
2.8
2.0
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.1
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
65
0.92
-0.00
1.0
1.2
100.83
79.35
%
—
6
65
7
74
0.94
-0.00
7.4
5.9
2.01
2.05
ug/l
—
7
74
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
73
0.96
-0.00
2.6
1.9
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
7
73
0.96
-0.00
1.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
20.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
86
0.93
-0.00
9.1
3.1
611.25
335.88
ug/l
—
8
76
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_INFECTIONS_SPECIFIC_PERINA_PERIOD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_INFECTIONS_SPECIFIC_PERINA_PERIOD | 1.84 [1.45, 2.34] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.613 |
During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 16734 females with P16_INFECTIONS_SPECIFIC_PERINA_PERIOD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_INFECTIONS_SPECIFIC_PERINA_PERIOD | 1.099 [0.9, 1.34] | 0.351 |
| Birth year | 0.987 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 113 out of 23642 males with P16_INFECTIONS_SPECIFIC_PERINA_PERIOD died.
Mortality risk
Mortality risk for people of age
years, who have P16_INFECTIONS_SPECIFIC_PERINA_PERIOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.158% | 0.199% |
| 5 | 1.081% | 1.32% |
| 10 | 2.695% | 3.159% |
| 15 | 5.399% | 6.062% |
| 20 | 9.582% | 10.507% |
Relationships between endpoints
↥Index endpoint: P16_INFECTIONS_SPECIFIC_PERINA_PERIOD – Infections specific to the perinatal period
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data